(Q43896989)

27 November 2017

Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type (English)

1 reference

27 November 2017

K F Foo

1

1 reference

27 November 2017

E H Tan

2

1 reference

27 November 2017

S S Leong

3

1 reference

27 November 2017

J T S Wee

4

1 reference

27 November 2017

T Tan

5

1 reference

27 November 2017

K W Fong

6

1 reference

27 November 2017

L Koh

7

1 reference

27 November 2017

B C Tai

8

1 reference

27 November 2017

L G Lian

9

1 reference

27 November 2017

D Machin

10

1 reference

27 November 2017

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

13

1 reference

27 November 2017

1

1 reference

27 November 2017

150-156

1 reference

Treatment of head and neck cancer: the role of chemotherapy

27 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

Activity of paclitaxel by three-hour infusion in Asian patients with metastatic undifferentiated nasopharyngeal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

A phase II study of combination paclitaxel and carboplatin in advanced nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

Chemotherapeutic treatment of recurrent and/or metastatic nasopharyngeal carcinoma: a retrospective analysis of 40 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

Gemcitabine: a pharmacologic and clinical overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

Chemotherapy of advanced non-small-cell lung cancer: a comparison of three active regimens. A randomized trial of the Italian Oncology Group for Clinical Research (G.O.I.R.C.).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF002

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDF002

1 reference

27 November 2017

1 reference